Academic literature on the topic 'Dialyzer reuse practice'

For 3 years starting in April 1989, in a 17-station, in-centre haemodialysis unit at the Toronto Western Hospital, re-use of dialysers was performed using the Renatron-2 Dialyser Reprocessing System with peracetic acid as a sterilant. During this period 40,234 treatments were carried out and dialysers were used an average of 4.2 times. Net savings, after taking into account the total costs of re-use, averaged Can $309,000,000 per year. There were no deaths and no discernible morbidity attributable to the practice of re-use. We conclude that dialyzer re-use is an effective way to reduce the costs of haemodialysis and is entirely safe providing that it is carried out properly.

Abstract. Although dialyzer reuse in chronic hemodialysis patients is commonly practiced in the United States, performance of reused dialyzers has not been extensively and critically evaluated. The present study analyzes data extracted from a multicenter clinical trial (the HEMO Study) and examines the effect of reuse on urea and β2-microglobulin (β2M) clearance by low-flux and high-flux dialyzers reprocessed with various germicides. The dialyzers evaluated contained either modified cellulosic or polysulfone membranes, whereas the germicides examined included peroxyacetic acid/acetic acid/hydrogen peroxide combination (Renalin®), bleach in conjunction with formaldehyde, glutaraldehyde or Renalin, and heated citric acid. Clearance of β2M decreased, remained unchanged, or increased substantially with reuse, depending on both the membrane material and the reprocessing technique. In contrast, urea clearance decreased only slightly (approximately 1 to 2% per 10 reuses), albeit statistically significantly with reuse, regardless of the porosity of the membrane and reprocessing method. Inasmuch as patient survival in the chronic hemodialysis population is influenced by clearances of small solutes and middle molecules, precise knowledge of the membrane material and reprocessing technique is important for the prescription of hemodialysis in centers practicing reuse.

Background: Asia is the largest, most populous and most heterogeneous continent in the world. The number of patients with end-stage renal disease is growing rapidly in Asia. Summary: A fully informed report on the status of dialysis therapies including hemodialysis (HD) is limited by the lack of systematic registries. Available data suggest remarkable heterogeneities, with some countries like Taiwan, Japan and Korea exhibiting well-established HD systems, high prevalence and universal access to all patients, while low- and low-middle income countries are unable to provide HD to eligible patients because of high cost and poor healthcare systems. Many Asian countries have unregulated dialysis units, with poor standards of delivery, quality control and outcome reporting. This leads to high mortality due to preventable complications like infections. Modeling data suggest that at least 2.9 million people need dialysis in Asia, which represents a gap in availability of dialysis to the tune of -66%. The population is projected to grow rapidly in the coming years. Several countries are expanding access to HD. Innovative modifications in dialysis practice are being made to optimize outcomes. It is important to develop robust systems of documentation and outcome reporting to evaluate the effects of such changes. HD needs to develop in conjunction with effective preventive programs and improvement of health systems. Key Messages: The practice of HD in Asia is growing and evolving. Rapid expansion will improve the currently dismal access to care for large sections of the population. Quality issues need to be addressed if the full benefit of this therapy is to reach the population. Developed countries of Asia can provide substantial messages to developing economies. HD programs must develop in conjunction with prevention efforts. Facts from East and West: (1) While developed Western and Asian countries provide end-stage renal disease patients full access to HD, healthcare systems from South and South-East Asia can offer access to HD only to a limited fraction of the patients in need. Even though the annual costs of HD are much lower in less developed countries (for instance 30 times lower in India compared to the US), patients often cannot afford costs not covered by health insurance. (2) The recommended dialysis pattern in the West is at least three sessions weekly with high-flux dialyzers. Studies from Shanghai and Taiwan might however indicate a benefit of twice versus thrice weekly sessions. In less developed Asian countries, a twice weekly pattern is common, sometimes with dialyzer reuse and inadequate water treatment. A majority of patients decrease session frequency or discontinue the program due to financial constraint. (3) As convective therapies are gaining popularity in Europe, penetration in Asia is low and limited by costs. (4) In Asian countries, in particular in the South and South-East, hepatitis and tuberculosis infections in HD patients are higher than in the West and substantially increase mortality. (5) Progress has recently been made in countries like Thailand and Brunei to provide universal HD access to all patients in need. Nevertheless, well-trained personnel, reliable registries and better patient follow-up would improve outcomes in low-income Asian countries.

Introduction: Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems. Objectives: To determine the knowledge and practices regarding end-stage renal disease and hemodialysis (HD) among dialysis technicians. Patients and Methods: Total of 157 technicians participated in a study carried out at Ahmedabad city of Gujrat state. A validated written questionnaire was distributed among dialysis technicians who gave their consent to participate in the study and responded questionnaires were analyzed. Data entry was made in Excel software in codes and analysis was conducted by SPSS software version 17.0 Results: Out of 157, 113 participants were routinely using online clearance monitoring. Around, 19.1% carried out disinfection of water loop once per week, while 23.6% and 28% were doing it once in 15 days and 30 days respectively. Reverse osmosis (RO) plant parameters like pH, hardness of water, chlorine content were checked once daily by 46.5% of technicians while 17.8% and 24.2% technicians were doing it once a week and once a month respectively. About 87.3% of technicians said that dialyzer was reused at their center. Accordingly, 33.8% and 51.6% of technicians were using formalin and per-acetic based disinfectants for dialyzer reprocessing. Additionally 7.6% of technicians were using hypochlorite as disinfectant at their center. Around 63.7% of technicians said they were not reprocessing dialyzers of HCV positive patients. They preferred to use single dialyzers in these subsets of patients at their center. Around, 79.6% of technicians said that endotoxin filter was installed in their dialysis unit. Likewise, 45.9% knew correctly the permissible level of endotoxin in RO water used for HD. Only 15.3% of technicians had correct knowledge of permissible level of bacteria in treated RO water as per association for the advancement of medical instrumentation (AAMI) standards. Conclusion: Better knowledge and awareness about dialysis standards among dialysis technicians will help in better patient’s care. Effective dialysis education campaign needs to be driven at regular intervals with relevant information among dialysis technicians to address the knowledge gap.

The effects of the dialysis membranes, hemodialysis (HD) session, and dialyzer reuse on markers of oxidative stress were studied. Patients with end stage renal disease who have undergone regular HD treatment three times a week were randomized in two study groups according to the type of HD membrane (cellulose acetate membrane (CA) vs. polysulfone membrane (PS)). All the patients participated of the two study groups and used the two different membranes. To analyze the parameters, the blood samples were colleted before and after HD sessions, in the irst use, 6th, 12th reuse of the membranes. The indicator parameters of oxidative stress analyzed were thiobarbituric acid reactive species (TBARS) and dichlorofluorescein reactive species (DRS) levels, carbonyl groups, antioxidant enzyme (catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px)), and non-enzymatic antioxidant (protein (PSH) and non-protein thiol groups (NPSH) and vitamin C). The results demonstrated that there was no significant difference in the markers of oxidative stress between the two membranes used. However, HD session contributed to the increase in TBARS (1st use and the 6th reuse), DRS (6th and 12th reuse), protein (all uses) and NPSH (1st use and 6th reuse) levels, GSH-Px activity (12th reuse) and to the decrease in vitamin C levels (all uses). The dialyzer reuse practice contributed to the increase in the PSH levels, to the decrease in the NPSH levels and to the reduction of the effects of the HD session on the TBARS levels. Therefore, the results obtained from this study revealed that regular HD with CA or PS membranes did not interfere with the oxidative status in the patients. However, HD session may contribute to the increase of oxidative stress and the dialyzer reuse practice appears to be efficient in the reduction of the peroxidation lipidic in these patients
Neste trabalho, foram investigados os efeitos do tipo de membrana de hemodiálise (HD) e da sua reutilização, bem como os efeitos da sessão de HD nos marcadores de estresse oxidativo. Pacientes com insuficiência renal crônica que realizavam HD três vezes por semana foram divididos em dois grupos, de acordo com o tipo de membrana usada (membrana de acetato de celulose (AC) X membrana de polisulfona (PS)). Todos os pacientes participaram dos dois grupos e usaram os dois tipos de membrana. Para análise dos parâmetros, amostras de sangue foram coletadas antes e após a sessão de HD, no 1º uso, 6º e 12º reuso das membranas. Os parâmetros indicadores de estresse oxidativo analisados foram: espécies reativas ao ácido tiobarbitúrico (TBARS), espécies reativas a diclorofluoresceína (DRS), carbonilação de proteínas, antioxidantes enzimáticos (catalase, superóxido dismutase e glutationa peroxidase (GSH-Px)) e antioxidantes não-enzimáticos (grupos tióis protéicos (PSH), grupos tióis não-protéicos (NPSH) e vitamina C). Os resultados demonstraram que não houve diferença significativa nos marcadores do estresse oxidativo entre as duas membranas usadas. Entretanto, houve um aumento dos níveis de TBARS após a sessão de HD (no 1º uso e no 6º reuso), de DRS (6º e 12º reuso), de PSH (em todos os usos), de NPSH (1º uso e 6º reuso), da atividade da GSH-Px (no 12º reuso) e uma diminuição dos níveis de vitamina C após a sessão de HD (em todos os usos). A reutilização das membranas contribuiu para o aumento dos níveis de PSH, para a diminuição dos níveis de NPSH e diminuiu os efeitos da sessão de HD sobre os níveis de TBARS. Portanto, os resultados obtidos neste estudo sugerem que HD com membrana de AC ou de PS não interfere de forma diferente nos marcadores de estresse oxidativo. Entretanto, a sessão de HD pode contribuir para o aumento da geração de estresse oxidativo e a reutilização dos dialisadores parece ser eficiente como forma de redução da peroxidação lipídica nos pacientes em HD